Article · Journal · 2025
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label …
John Amuasi, Anthony Afum-Adjei Awuah
The Lancet Infectious Diseases
Go to the publisher
- Citations
- 12Citationsfrom other works
- Field-weighted impact
- —Field-weighted impactNot yet scored
- Among its field
- —Among its fieldNot yet scored
- Authors
- 2Authorsfrom 0 institutions